Developing and Piloting FUERTE: Federally qUalified health centers Engaging Hispanic men at Risk of DiabeTEs
Project Number1K23DK139410-01A1
Former Number1K23DK139410-01
Contact PI/Project LeaderGONZALEZ, CHRISTOPHER JESUS
Awardee OrganizationWEILL MEDICAL COLL OF CORNELL UNIV
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Diabetes and diabetes-related complications are disproportionately more prevalent among Hispanic men. The
Diabetes Prevention Program (DPP) is an intensive lifestyle intervention that effectively reduces the risk of
diabetes; however, Hispanic men are relatively underrepresented in the program and less likely to remain
engaged in it, which decreases the likelihood of reaching the program’s 5% weight loss goal. Federally
Qualified Health Centers (FQHCs) serve many Hispanic adults but have been understudied as settings to test
implementation strategies to potentially address these inequities. The proposed K23 career development
award will equip Dr. Christopher J. Gonzalez with scholarly training and practical experience as he becomes
an independent clinician-investigator conducting implementation trials that reduce racial and ethnic inequities
in diabetes. It will enable him to develop, implement, and evaluate FUERTE (Federally qUalified health centers
Engaging Hispanic men at Risk for diabeTEs), a multi-component implementation strategy for FQHCs to
facilitate referrals of Hispanic men to the DPP and to support their continued engagement in the program.
FUERTE is anticipated to include i) information sessions for providers, ii) direct outreach to DPP-eligible
Hispanic men, and iii) tailored content, delivered through WhatsApp, meant to increase the DPP’s relevance
and acceptability to Hispanic men enrolled in the program, while encouraging additional peer support. First,
(Aim 1) qualitative interviews with 30 stakeholders at FQHCs will identify barriers to referring and supporting
Hispanic men at FQHCs to the DPP, informing the development of a theory-driven implementation strategy
that facilitates DPP referrals and supports engagement of Hispanic men in the DPP. Second, (Aim 2)
incorporating stakeholder feedback, focus groups with DPP-eligible Hispanic men at an FQHC will facilitate
user-centered content development for the multi-component implementation strategy. Third, (Aim 3) the multi-
component implementation strategy will be piloted in a real-world hybrid implementation trial among 40 DPP-
referred Hispanic men at an FQHC and assessed for feasibility using the evaluative components of the RE-
AIM (Reach, Efficacy/Effectiveness, Adoption, Implementation, and Maintenance) framework. DPP
participation, weight change, and A1C change will be assessed. Through formal didactics and training from a
team of experienced mentors and multidisciplinary advisors, Dr. Gonzalez will acquire knowledge and skills in
implementation theory, stakeholder-engaged intervention design, cultural adaptation, user-centered design,
real-world trials, and implementation evaluation. His environment at Weill Cornell Medical College, including
the Cornell Center for Health Equity, and Settlement Health, an FQHC where Dr. Gonzalez practices internal
medicine and with whom he has partnered for this research, is ideal to support his training, complete the
proposed aims, and achieve his goal of becoming an independent clinician-investigator and apply for an R01
testing the implementation strategy developed and piloted in this award in a future large-scale multi-site trial.
Public Health Relevance Statement
PROJECT NARRATIVE
Despite a relatively high prevalence of diabetes and diabetes complications among Hispanic men, few are
referred to and remain engaged in lifestyle interventions that effectively reduce the risk of developing diabetes.
This project seeks to develop, implement, and evaluate a multi-component implementation strategy for
Federally Qualified Health Centers to facilitate referrals of Hispanic men to the Diabetes Prevention Program
and to support their continued engagement in the program. Research from this project will result in a novel and
scalable implementation strategy that has the potential to address racial and ethnic inequities in diabetes.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptionAdultAffectAmputationAwardBody Weight ChangesBody Weight decreasedCaringCessation of lifeCollaborationsComplications of Diabetes MellitusDataDevelopmentDiabetes MellitusDiabetes preventionDoctor of PhilosophyEffectivenessEligibility DeterminationEnrollmentEnvironmentFederally Qualified Health CenterFeedbackFocus GroupsFoundationsFundingFutureGenderGoalsHealthHealth Services ResearchHigh PrevalenceHispanicHispanic menHybridsInequityInternal MedicineInterventionInterviewK-Series Research Career ProgramsKidney FailureKnowledgeKnowledge acquisitionLeadLower ExtremityMaintenanceMentored Patient-Oriented Research Career Development AwardMentorsNational Institute of Diabetes and Digestive and Kidney DiseasesNew YorkNew York CityNot Hispanic or LatinoPatientsPersonsPopulationPrediabetes syndromePrevalencePrevention ResearchPrimary CareProviderQualifyingQualitative MethodsRecommendationResearchResearch DesignResearch PersonnelResearch Project GrantsRisk ReductionTestingTrainingTraining SupportTranslational ResearchTranslationsVisual impairmentWorkcardiometabolismcareercareer developmentcostdesigndiabetes prevention programdiabetes riskeffective interventioneffectiveness/implementation trialethnic disparityevidence baseexperiencehealth equityhigh riskhispanic communityimplementation evaluationimplementation scienceimplementation strategyimplementation trialimprovedlifestyle interventionmarginalized populationmedical schoolsmulti-site trialmultidisciplinarynoveloutreachpatient orientedpeer supportpilot testpost-doctoral trainingpreventpreventive interventionprimary care practiceprogramsracial disparityrecruitresearch and developmentskillstheoriestherapy designuser centered designwhite men
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
060217502
UEI
YNT8TCJH8FQ8
Project Start Date
01-December-2024
Project End Date
30-November-2029
Budget Start Date
01-December-2024
Budget End Date
30-November-2025
Project Funding Information for 2025
Total Funding
$170,100
Direct Costs
$157,500
Indirect Costs
$12,600
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Diabetes and Digestive and Kidney Diseases
$170,100
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1K23DK139410-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1K23DK139410-01A1
Patents
No Patents information available for 1K23DK139410-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1K23DK139410-01A1
Clinical Studies
No Clinical Studies information available for 1K23DK139410-01A1
News and More
Related News Releases
No news release information available for 1K23DK139410-01A1
History
No Historical information available for 1K23DK139410-01A1
Similar Projects
No Similar Projects information available for 1K23DK139410-01A1